We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$255B
AUM Growth
-$3.63B
Cap. Flow
-$5.97B
Cap. Flow %
-2.34%
Top 10 Hldgs %
12.76%
Holding
4,482
New
462
Increased
1,845
Reduced
1,866
Closed
145

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$311M
2
EXR icon
Extra Space Storage
EXR
+$293M
3
KO icon
Coca-Cola
KO
+$246M
4
TCO
Taubman Centers Inc.
TCO
+$211M
5
NTAP icon
NetApp
NTAP
+$188M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.19%
3 Financials 13.69%
4 Communication Services 8.77%
5 Real Estate 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRMR icon
4001
Larimar Therapeutics
LRMR
$397M
$5K ﹤0.01%
+12
New +$5.02K
LXRX icon
4002
Lexicon Pharmaceuticals
LXRX
$1.04B
$5K ﹤0.01%
+680
New +$4.99K
MDGL icon
4003
Madrigal Pharmaceuticals
MDGL
$11.4B
$5K ﹤0.01%
+61
New +$5.12K
NG icon
4004
NovaGold Resources
NG
$2.66B
$5K ﹤0.01%
1,420
-23,091
-94% -$87.6K
NRC icon
4005
NRC Health Common Stock
NRC
$419M
$5K ﹤0.01%
+381
New +$5.4K
PTCT icon
4006
PTC Therapeutics
PTCT
$6.26B
$5K ﹤0.01%
105
-93,011
-100% -$5.43M
RARE icon
4007
Ultragenyx Pharmaceutical
RARE
$2.56B
$5K ﹤0.01%
+53
New +$4.12K
SAGE
4008
DELISTED
Sage Therapeutics
SAGE
$5K ﹤0.01%
+74
New +$4.76K
DCOY
4009
Decoy Therapeutics
DCOY
$2.09M
0
TBPH icon
4010
Theravance Biopharma
TBPH
$873M
$5K ﹤0.01%
+373
New +$5.79K
TGTX icon
4011
TG Therapeutics
TGTX
$8.19B
$5K ﹤0.01%
323
-108,163
-100% -$1.71M
VANI icon
4012
Vivani Medical
VANI
$112M
$5K ﹤0.01%
+14
New +$4.49K
VCYT icon
4013
Veracyte
VCYT
$4.77B
$5K ﹤0.01%
+470
New +$4.63K
VSTM icon
4014
Verastem
VSTM
$536M
$5K ﹤0.01%
+58
New +$6.13K
XBIT icon
4015
XBiotech
XBIT
$68.3M
$5K ﹤0.01%
+274
New +$5.68K
XOMA
4016
DELISTED
Xoma
XOMA
$5K ﹤0.01%
+65
New +$4.68K
ATYR
4017
aTyr Pharma
ATYR
$47.1M
$5K ﹤0.01%
+18
New +$5.59K
VIVS
4018
VivoSim Labs
VIVS
$1.35M
$5K ﹤0.01%
+5
New +$5.59K
RVNC
4019
DELISTED
Revance Therapeutics, Inc.
RVNC
$5K ﹤0.01%
+161
New +$4.14K
CDMO
4020
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$5K ﹤0.01%
+571
New +$5.49K
ALIM
4021
DELISTED
Alimera Sciences
ALIM
$5K ﹤0.01%
+76
New +$5.24K
ASXC
4022
DELISTED
Asensus Surgical, Inc.
ASXC
$5K ﹤0.01%
+140
New +$6.45K
TRVN
4023
DELISTED
Trevena, Inc.
TRVN
$5K ﹤0.01%
+1
New +$4.23K
SIEN
4024
DELISTED
Sientra, Inc.
SIEN
$5K ﹤0.01%
+21
New +$4.29K
NSTG
4025
DELISTED
NanoString Technologies, Inc.
NSTG
$5K ﹤0.01%
+340
New +$4.54K

Similar funds

Invesco's Q2 2015 Portfolio in Review

As of Q2 2015, Invesco held 4,482 positions worth $255B, down 1.4% from $258B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Invesco's Q2 2015 filing shows 462 new, 1,845 increased, 1,866 reduced and 145 closed positions. Its largest new stake was Anthem, Inc.: 1,170,000 shares worth $61.6M. The largest sale was Fiat Chrysler Automobiles N.V., an estimated $3.11B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

  • Invesco's largest Q2 2015 buy was Anthem, Inc.: 1,170,000 shares worth $61.6M.
  • Invesco added most to Equinix in Q2 2015, an estimated $311M increase.
  • Invesco's biggest Q2 2015 reduction was Fiat Chrysler Automobiles N.V., cutting an estimated $3.11B.
  • Invesco fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $126M.
  • Invesco's ten largest holdings make up 13% of its $255B portfolio in Q2 2015.
  • Invesco opened 462 new positions and closed 145 in Q2 2015.
  • Invesco's portfolio value fell 1.4% quarter-over-quarter to $255B.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.